These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 24286707

  • 1. Inhibition of endocannabinoid-degrading enzyme fatty acid amide hydrolase increases atherosclerotic plaque vulnerability in mice.
    Hoyer FF, Khoury M, Slomka H, Kebschull M, Lerner R, Lutz B, Schott H, Lütjohann D, Wojtalla A, Becker A, Zimmer A, Nickenig G.
    J Mol Cell Cardiol; 2014 Jan; 66():126-32. PubMed ID: 24286707
    [Abstract] [Full Text] [Related]

  • 2. Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice.
    Lenglet S, Thomas A, Soehnlein O, Montecucco F, Burger F, Pelli G, Galan K, Cravatt B, Staub C, Steffens S.
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):215-23. PubMed ID: 23241405
    [Abstract] [Full Text] [Related]

  • 3. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
    Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D.
    J Pharmacol Exp Ther; 2005 Apr; 313(1):352-8. PubMed ID: 15579492
    [Abstract] [Full Text] [Related]

  • 4. Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase.
    Haller VL, Stevens DL, Welch SP.
    Eur J Pharmacol; 2008 Dec 14; 600(1-3):50-8. PubMed ID: 18762181
    [Abstract] [Full Text] [Related]

  • 5. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA, Kaiser N, Monory K, Lutz B.
    Neuropharmacology; 2008 Jan 14; 54(1):141-50. PubMed ID: 17709120
    [Abstract] [Full Text] [Related]

  • 6. Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages.
    Sun YX, Tsuboi K, Zhao LY, Okamoto Y, Lambert DM, Ueda N.
    Biochim Biophys Acta; 2005 Oct 01; 1736(3):211-20. PubMed ID: 16154384
    [Abstract] [Full Text] [Related]

  • 7. Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats.
    Kwilasz AJ, Abdullah RA, Poklis JL, Lichtman AH, Negus SS.
    Behav Pharmacol; 2014 Apr 01; 25(2):119-29. PubMed ID: 24583930
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality.
    Naidu PS, Varvel SA, Ahn K, Cravatt BF, Martin BR, Lichtman AH.
    Psychopharmacology (Berl); 2007 May 01; 192(1):61-70. PubMed ID: 17279376
    [Abstract] [Full Text] [Related]

  • 9. Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates.
    Justinova Z, Mangieri RA, Bortolato M, Chefer SI, Mukhin AG, Clapper JR, King AR, Redhi GH, Yasar S, Piomelli D, Goldberg SR.
    Biol Psychiatry; 2008 Dec 01; 64(11):930-7. PubMed ID: 18814866
    [Abstract] [Full Text] [Related]

  • 10. The effects of fatty acid amide hydrolase and monoacylglycerol lipase inhibitor treatments on lipopolysaccharide-induced airway inflammation in mice.
    Abohalaka R, Bozkurt TE, Nemutlu E, Onder SC, Sahin-Erdemli I.
    Pulm Pharmacol Ther; 2020 Jun 01; 62():101920. PubMed ID: 32416152
    [Abstract] [Full Text] [Related]

  • 11. The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB₁- and FAAH-independent mechanisms.
    Bosier B, Muccioli GG, Lambert DM.
    Br J Pharmacol; 2013 Jun 01; 169(4):794-807. PubMed ID: 22970888
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain.
    Jiang HX, Ke BW, Liu J, Ma G, Hai KR, Gong DY, Yang Z, Zhou C.
    Anesth Analg; 2019 Aug 01; 129(2):587-597. PubMed ID: 29863609
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells.
    Li H, Wood JT, Whitten KM, Vadivel SK, Seng S, Makriyannis A, Avraham HK.
    Br J Pharmacol; 2013 Oct 01; 170(3):489-505. PubMed ID: 23347118
    [Abstract] [Full Text] [Related]

  • 14. The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.
    Scherma M, Medalie J, Fratta W, Vadivel SK, Makriyannis A, Piomelli D, Mikics E, Haller J, Yasar S, Tanda G, Goldberg SR.
    Neuropharmacology; 2008 Jan 01; 54(1):129-40. PubMed ID: 17904589
    [Abstract] [Full Text] [Related]

  • 15. Fatty Acid Amide Hydrolase (FAAH) Inhibition Modulates Amyloid-Beta-Induced Microglia Polarization.
    Grieco M, De Caris MG, Maggi E, Armeli F, Coccurello R, Bisogno T, D'Erme M, Maccarrone M, Mancini P, Businaro R.
    Int J Mol Sci; 2021 Jul 19; 22(14):. PubMed ID: 34299330
    [Abstract] [Full Text] [Related]

  • 16. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
    Walentiny DM, Vann RE, Wiley JL.
    Neuropharmacology; 2015 Jun 19; 93():237-42. PubMed ID: 25698527
    [Abstract] [Full Text] [Related]

  • 17. Effects of the fatty acid amide hydrolase inhibitor URB597 on coping behavior under challenging conditions in mice.
    Haller J, Aliczki M, Pelczer KG, Spitzer K, Balogh Z, Kantor S.
    Psychopharmacology (Berl); 2014 Feb 19; 231(3):593-601. PubMed ID: 24037493
    [Abstract] [Full Text] [Related]

  • 18. Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells.
    Winkler K, Ramer R, Dithmer S, Ivanov I, Merkord J, Hinz B.
    Oncotarget; 2016 Mar 22; 7(12):15047-64. PubMed ID: 26930716
    [Abstract] [Full Text] [Related]

  • 19. Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson's disease.
    Celorrio M, Fernández-Suárez D, Rojo-Bustamante E, Echeverry-Alzate V, Ramírez MJ, Hillard CJ, López-Moreno JA, Maldonado R, Oyarzábal J, Franco R, Aymerich MS.
    Brain Behav Immun; 2016 Oct 22; 57():94-105. PubMed ID: 27318096
    [Abstract] [Full Text] [Related]

  • 20. Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat.
    Cippitelli A, Cannella N, Braconi S, Duranti A, Tontini A, Bilbao A, Defonseca FR, Piomelli D, Ciccocioppo R.
    Psychopharmacology (Berl); 2008 Jul 22; 198(4):449-60. PubMed ID: 18446329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.